Detalhe da pesquisa
1.
Cost-effectiveness analysis of emicizumab prophylaxis in patients with haemophilia A in India.
Haemophilia
; 30(2): 426-436, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147060
2.
Multi-criteria decision making to validate performance of RBC-based formulae to screen [Formula: see text]-thalassemia trait in heterogeneous haemoglobinopathies.
BMC Med Inform Decis Mak
; 24(1): 5, 2024 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38167309
3.
Revisiting fetal hemoglobin inducers in beta-hemoglobinopathies: a review of natural products, conventional and combinatorial therapies.
Mol Biol Rep
; 49(3): 2359-2373, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34822068
4.
Exploring the crosstalk between long non-coding RNAs and microRNAs to unravel potential prognostic and therapeutic biomarkers in ß-thalassemia.
Mol Biol Rep
; 49(7): 7057-7068, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717472
5.
Diagnostic Dilemma of Hemoglobinopathies Using High Performance Liquid Chromatography Alone: A Case Report from a Resource-Constrained Setting.
Hemoglobin
; 46(4): 256-259, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577529
6.
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial.
Lancet
; 396(10262): 1563-1573, 2020 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33189178
7.
MicroRNA expression patterns in HbE/ß-thalassemia patients: The passwords to unlock fetal hemoglobin expression in ß-hemoglobinopathies.
Blood Cells Mol Dis
; 87: 102523, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33242839
8.
Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-ß thalassemia - a pilot study from a tertiary care Centre of India.
Blood Cells Mol Dis
; 88: 102544, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33610115
9.
Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies.
Blood Cells Mol Dis
; 87: 102525, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338697
10.
Efficacy and safety profile of generic imatinib in patients with newly diagnosed chronic myeloid leukemia-chronic phase: sharing experience of a hemato-oncology center from eastern India.
Ann Hematol
; 100(1): 85-96, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33025163
11.
Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.
Am J Hematol
; 96(9): 1120-1130, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34062004
12.
Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.
Am J Hematol
; 96(6): 708-718, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33755235
13.
Utility of 18F-fluorodeoxyglucose PET-CT scan in detecting bone marrow involvement in lymphoma.
Indian J Med Res
; 154(5): 691-698, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35532587
14.
First Report of the 3'-Untranslated Region +1506 (A>C) [NM_000518.5: c.*32A>C] mutation on the ß-Globin Gene in the Indian Population.
Hemoglobin
; 45(5): 325-328, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34886762
15.
Comparative Efficacy and Safety Between Deferiprone and Deferasirox with Special Reference to Serum Ferritin Level and Cardiac Function in Bengali ß-Thalassemia Major Children.
Hemoglobin
; 45(5): 296-302, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758688
16.
Proposed rituximab biosimilar BCD-020 versus reference rituximab for treatment of patients with indolent non-Hodgkin lymphomas: An international multicenter randomized trial.
Hematol Oncol
; 38(1): 67-73, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31724191
17.
Changes in Different Cytokines (IL-2, TNF-α, and IFN-γ) Profile in Acquired Aplastic Anemia Patients: A Study From Eastern India.
J Pediatr Hematol Oncol
; 42(3): 185-192, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32032240
18.
Implications of Population Screening for Thalassemias and Hemoglobinopathies in Rural Areas of West Bengal, India: Report of a 10-Year Study of 287,258 Cases.
Hemoglobin
; 44(6): 432-437, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33059511
19.
Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study.
Am J Hematol
; 97(3): E83-E86, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882831
20.
Minimal Residual Disease in the Management of B-Cell Acute Lymphoblastic Leukemia: A Systematic Review of Studies from Indian Settings.
Indian J Hematol Blood Transfus
; 40(1): 1-11, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38312181